Aptose Biosciences Shares Rise 55% on Q4 Financial Results and Promising Clinical Trials
Source: Streetwise Reports  (3/24/21)
Aptose Biosciences Inc. shares traded 55% higher after the company posted Q4 and FY/20 financial results and provided an update on the status of its drug candidates in ongoing clinical trials investigating treatments for life threatening hematologic cancers. More >

Investor Campbell Becher's Three Core Assets
Source: Streetwise Reports  (3/22/21)
The former Bay Street investment banker is finding himself going narrower and deeper. More >

Mental Health Firm Partners with Merck on Treatment-Resistant Depression Trial
Source: Streetwise Reports  (3/22/21)
Novamind Inc. reported it is teaming up with Merck to conduct a new Phase 2a study addressing treatment-resistant depression at a key clinical research site owned by its subsidiary company Cedar Clinical Research. More >

The Covid-19 Issue Too Many Are Ready to Overlook, and the Investing Opportunity It Creates
Source: KSS, MD, PhD, for Streetwise Reports  (3/22/21)
Have we forgotten about good Covid 19 Therapeutics? KSS MD PhD, editor-in-chief of PubBio.co, discusses three gems investors should know about. More >

Clovis Oncology Shares Rise on Positive Data from Phase 3 Ovarian Cancer Trial
Source: Streetwise Reports  (3/19/21)
Shares of Clovis Oncology Inc. traded 55% higher after it reported that in the Phase 3 ARIEL4 study Rubraca (rucaparib) significantly improved progression-free survival versus chemotherapy in patients with later-line ovarian cancer associated with a BRCA Mutation. More >

Biopharma Advances Alcohol-Associated Hepatitis Trial, Receives Analgesia Drug Approval
Source: Streetwise Reports  (3/17/21)
These corporate events and the Q4/20 financials of DURECT are summarized in an H.C. Wainwright & Co. report. More >

Health Tech Company to Provide Patient Care Platform for 25+ Florida Nursing Facilities
Source: Streetwise Reports  (3/17/21)
Reliq Health Technologies reported it entered into a new contract with a physician practice in Florida to provide its iUGO Care platform to over 25 skilled nursing facilities statewide. More >

Pharma Developer to Release Topline Data from Phase 2b COVID-19 Trial by Month-End
Source: Streetwise Reports  (3/16/21)
Algernon Pharmaceuticals reported that it expects to release topline results from the Phase 2b portion of its multinational Phase 2b/3 COVID-19 Ifenprodil study sometime during the last week of March 2021. More >

Oncternal Therapeutics Shares Trade Higher After Firm Reports 39% Growth in FY20 Grant Revenue
Source: Streetwise Reports  (3/12/21)
Oncternal Therapeutics shares traded 18% higher after the company reported Q4/20 and FY/20 financial results showing higher revenues from grants and improved operating expense without incurring any reductions in Research and Development activities. More >

Vir Shares Head Higher as Phase 3 COVID-19 Trial with GSK Achieves 85% Reduction in Hospitalization and Death
Source: Streetwise Reports  (3/11/21)
Vir Biotechnology shares traded 30% higher after the company together with its development partner GlaxoSmithKline reported that in the Phase 3 COMET-ICE trial VIR-7831 was shown to reduce hospitalization and risk of death in early treatment of adults with SARS-CoV-2. More >

Biopharma Begins Phase 2 COVID Clinical Trial
Source: Streetwise Reports  (3/10/21)
An update on two of Can-Fite BioPharma's studies involving its lead drug candidate Piclidenoson is provided in a Dawson James report. More >

Materialise Shares Print 27% Higher on Upward Trend in Q4 Revenue
Source: Streetwise Reports  (3/9/21)
Shares of 3D printing firm Materialise NV traded higher after the company reported FY/20 financial results and indicated that sequential quarterly revenue rebounded, increasing by 11.1% in Q4/20. More >

RadNet Shares Rise 17% on Record Q4 Revenue and Bright Outlook for 2021
Source: Streetwise Reports  (3/8/21)
Shares of RadNet Inc. reached a new 52-week high after the diagnostic imaging company reported record revenue and adjusted EBITDA for Q4/21 and offered positive financial guidance for FY/21. More >

Two Studies of Life Sciences Firm's Feed Supplement to Be Featured in Journal
Source: Streetwise Reports  (3/8/21)
The positive results of two studies of Avivagen's OxC-beta in broiler poultry are slated for publication in Poultry Science. More >

Investors Seeing Green as FDA Approves Second Sight Medical's Argus 2s Retinal Prosthesis System
Source: Streetwise Reports  (3/5/21)
Second Sight Medical Products shares trade more than 400% higher after the company reported that the FDA granted approval for its Argus 2s Retinal Prosthesis System designed to deliver useful artificial vision to blind individuals diagnosed with retinitis pigmentosa. More >

Amgen Offers $1.9 Billion to Acquire Five Prime Therapeutics
Source: Streetwise Reports  (3/4/21)
Five Prime Therapeutics shares traded 78% higher after the company reported it entered into a definitive agreement to be acquired by biotech giant Amgen for $38 per share in cash. More >

U.S. Biopharma Making a 'Bold Move into a Large Market Opportunity'
Source: Streetwise Reports  (3/3/21)
This latest undertaking of Dicerna Pharmaceuticals and the near-term catalysts of some of its other programs are described in an H.C. Wainwright & Co. report. More >

Virtual HealthCare Tech Firm Reports Q2 Sequential Revenue Growth of 108%
Source: Streetwise Reports  (3/3/21)
Reliq Health Technologies reported financial results for Q2/21 that demonstrated significant increases in quarterly revenues and gross margins; management expects to achieve profitability in the quarter ending June 30, 2021. More >

FDA Grants Expanded Use in General Surgery for Asensus Surgical's Robotic Laparoscopic Platform
Source: Streetwise Reports  (3/3/21)
Asensus Surgical shares traded 16.5% higher after the company reported it received clearance from the U.S. Food & Drug Administration for its Senhance© Surgical System for use in general surgical procedures. More >

Biopharma Chooses Firm to Co-Conduct Psychedelic Dose Trial
Source: Streetwise Reports  (3/2/21)
Algernon Pharmaceuticals aims to begin the study as soon as it receives the drug from the manufacturer. More >

Virtual HealthCare Tech Firm Contracts to Provide Patient Care Platform to US Nephrology Clinic
Source: Streetwise Reports  (2/26/21)
Reliq Health Technologies reported it signed a new agreement with a Texas-based nephrology clinic to provide its iUGO Care platform to patients with chronic kidney disease. More >

Pandion Shares Trade Up 134% on $1.85 Billion Acquisition by Merck
Source: Streetwise Reports  (2/25/21)
Pandion Therapeutics shares reached a new 52-week high after the company reported it agreed to be acquired by pharmaceutical giant Merck & Co. in an all cash transaction for $60 per share. More >

Telehealth Tech Company Continues Rapid Growth in COVID-Changed Landscape
Source: Streetwise Reports  (2/24/21)
Reliq Health introduces iUGO Home services and just added a care management network in California with 50 clinics and over 500 physicians. More >

Analyst: All Systems Are Go for Testing, Testing and More Testing
Source: Streetwise Reports  (2/24/21)
This Dawson James report explains why ProPhase Labs is perfectly positioned to benefit from expanded COVID testing.
More >

U.S. Cannabis Company 'Cashed Up with Catalysts Materializing'
Source: Streetwise Reports  (2/24/21)
The many reasons why Columbia Care is 'due for a catch-up trade' are discussed in an Echelon Capital Markets report. More >